Last reviewed · How we verify
Placebo depot — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo depot (Placebo depot) — Otsuka Pharmaceutical Development & Commercialization, Inc.. Placebo depot does not have an active pharmacological mechanism; it is used as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo depot TARGET | Placebo depot | Otsuka Pharmaceutical Development & Commercialization, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo depot CI watch — RSS
- Placebo depot CI watch — Atom
- Placebo depot CI watch — JSON
- Placebo depot alone — RSS
Cite this brief
Drug Landscape (2026). Placebo depot — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-depot. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing